• Eisenhofer G. Analytical differences between the
determination of plasma catecholamines by liquid chromatography with electrochemical
detection and by radioenzymatic assay. J Chromatography 377: 328-331, 1986.
• Eisenhofer G., D.S. Goldstein, R. Stull, H.R. Keiser, T.
Sunderland, D.L. Murphy and I.J. Kopin. Simultaneous liquid chromatographic determination
of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma,
and their responses to monoamine oxidase inhibition. Clin Chem 32: 2030-2033, 1986.
• Goldstein D.S., R. Stull, G. Eisenhofer, J.C. Sisson, A. Weder,
S.D. Averbuch and H.R. Keiser. Plasma dihydroxyphenylalanine and catecholamines in
neuroblastoma or pheochromocytoma. Ann Int Med 105: 887-888, 1986.
• Goldstein DS, Stull R, Markey SP, Marks E, Keiser HR.
Dihydrocaffeic acid: A common contaminant in the liquid chromatographic-electrochemical
measurement of plasma catecholamines in man. J Chromatog 311:148-153, 1984.
• Goldstein D.S., G. Eisenhofer, R. Stull, C.J. Folio, H.R. Keiser
and I.J. Kopin. Plasma dihydroxyphenylglycol and the intraneuronal disposition of
norepinephrine in humans. J Clin Invest 81: 213-220, 1988.
• Goldstein D. S. and G. Eisenhofer. Plasma catechols - What do
they mean? News Physiol Sci 3: 138-144, 1988.
• Lenders J.W.M., G. Eisenhofer, I. Armando, H.R. Keiser, D.S.
Goldstein and I.J. Kopin. Determination of plasma metanephrines by liquid chromatography
with electrochemical detection. Clin Chem 39: 97-103, 1993.
• Holmes C., G. Eisenhofer and D.S. Goldstein. Improved assay of
plasma dihydroxyphenylacetic acid and other catechols using liquid chromatography with
electrochemical detection. J Chromatography 653: 131-138, 1994.
• Lenders J.W.M., H.R. Keiser, D.S. Goldstein, J.J. Willemsen, P.
Friberg, M-C. Jacobs, P.W.C. Kloppenborg, T. Thien and G. Eisenhofer. Plasma metanephrines
in the diagnosis of pheochromocytoma. Ann Int Med 123: 101-109, 1995.
• Eisenhofer G., B. Rundqvist, A. Åneman, P. Friberg, N. A.
Dakak, I.J. Kopin, M-C. Jacobs and J.W.M. Lenders. Regional release and removal of
catecholamines and extraneuronal metabolism to metanephrines. J Clin Endocrinol Metab 80:
3009-3017, 1995.
• Eisenhofer G., P. Friberg, K. Pacak, D.S. Goldstein, D.L.
Murphy, C. Tsigos, A.A. Quyyumi, H. G. Brunner and J.W.M. Lenders. Plasma metanephrines:
do they provide useful information about sympatho-adrenal function and catecholamine
metabolism? Clin Sci 88: 533-542, 1995.
• Eisenhofer G., A. Åneman, D Hooper and P. Friberg. Mesenteric
organ production, hepatic metabolism, and renal elimination of norepinephrine and its
metabolites in humans. J Neurochem 66: 1565-1573, 1996.
• Eisenhofer G., H. Keiser, P. Friberg, E. Mezey, T-T Huynh, B.
Hiremagalur, T. Ellingson, S. Duddempudi and J.W.M. Lenders. Plasma metanephrines are
markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin
Endocrinol Metab, 83: 2175-2185, 1998.
• Eisenhofer G. and J.W.M. Lenders. Clues to the diagnosis of
pheochromocytoma from the differential tissue metabolism of catecholamines. Advances in
Pharmacology, 42: 374-377, 1998.
• Eisenhofer G., J.W.M. Lenders, W.M. Linehan, M.M. Walther, D.S.
Goldstein and H.R. Keiser. Plasma normetanephrine and metanephrine for detecting
pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. New
England Journal of Medicine, 340: 1872-1879, 1999.
